About Adagio Medical Holdings, Inc.
https://adagiomedical.comAdagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.
CEO
Todd Usen
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C
Price Target
Institutional Ownership
PERCEPTIVE ADVISORS LLC
Shares:9.88M
Value:$8.68M
ADAGE CAPITAL PARTNERS GP, L.L.C.
Shares:1.06M
Value:$930.32K
RTW INVESTMENTS, LP
Shares:209.36K
Value:$184.01K
Summary
Showing Top 3 of 17
About Adagio Medical Holdings, Inc.
https://adagiomedical.comAdagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $5.69M ▲ | $-10.12M ▼ | 0% | $-0.66 ▼ | $-9.18M ▼ |
| Q2-2025 | $0 | $4.38M ▼ | $-3.95M ▲ | 0% | $-0.26 ▲ | $-4.45M ▲ |
| Q1-2025 | $0 ▲ | $7.14M ▼ | $-7.71M ▲ | 0% ▼ | $-0.5 ▲ | $-7.13M ▲ |
| Q4-2024 | $-143K ▼ | $50.37M ▲ | $-52.8M ▼ | 36.93K% ▲ | $-3.55 ▼ | $-56.27M ▼ |
| Q3-2024 | $185K | $10.24M | $-4.63M | -2.5K% | $-0.32 | $-3.63M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $4.67M ▼ | $31.55M ▼ | $32.86M ▲ | $-1.31M ▼ |
| Q2-2025 | $8.2M ▼ | $35.88M ▼ | $27.21M ▼ | $8.67M ▼ |
| Q1-2025 | $12.96M ▼ | $41.34M ▼ | $28.94M ▲ | $12.4M ▼ |
| Q4-2024 | $20.59M ▼ | $48.45M ▼ | $28.54M ▼ | $19.91M ▼ |
| Q3-2024 | $28.26M | $107.2M | $30.64M | $76.56M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-10.12M ▼ | $-3.01M ▲ | $-520K ▼ | $0 | $-3.53M ▲ | $-3.53M ▲ |
| Q2-2025 | $-3.95M ▲ | $-4.66M ▲ | $-10K ▲ | $0 | $-4.76M ▲ | $-4.67M ▲ |
| Q1-2025 | $-7.71M ▲ | $-7.21M ▼ | $-335K ▲ | $0 | $-7.62M ▲ | $-7.55M ▲ |
| Q4-2024 | $-57.37M ▼ | $-7.11M ▲ | $-702K ▼ | $0 ▼ | $-7.67M ▼ | $-7.81M ▲ |
| Q3-2024 | $-4.63M | $-8.66M | $-609K | $990K | $26.21M | $-9.27M |
CEO
Todd Usen
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C
Price Target
Institutional Ownership
PERCEPTIVE ADVISORS LLC
Shares:9.88M
Value:$8.68M
ADAGE CAPITAL PARTNERS GP, L.L.C.
Shares:1.06M
Value:$930.32K
RTW INVESTMENTS, LP
Shares:209.36K
Value:$184.01K
Summary
Showing Top 3 of 17